Helsinki - Free Realtime Quote EUR

Remedy Entertainment Oyj (REMEDY.HE)

Compare
12.82 -0.38 (-2.88%)
As of 2:32 PM GMT+2. Market Open.
Loading Chart for REMEDY.HE
DELL
  • Previous Close 13.20
  • Open 13.42
  • Bid 12.82 x --
  • Ask 12.84 x --
  • Day's Range 12.72 - 13.66
  • 52 Week Range 12.72 - 27.50
  • Volume 8,910
  • Avg. Volume 5,307
  • Market Cap (intraday) 174.021M
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) -1.37
  • Earnings Date Nov 1, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date Apr 14, 2023
  • 1y Target Est 20.00

Remedy Entertainment Oyj, a video game company, engages in the development and sale of games for PC and console platforms in Finland. It primarily creates story-driven and visually stunning action games. The company also provides franchises under the Alan Wake, Control, and Max Payne brand names. Remedy Entertainment Oyj was incorporated in 1995 and is headquartered in Espoo, Finland.

www.remedygames.com

361

Full Time Employees

December 31

Fiscal Year Ends

Recent News: REMEDY.HE

View More

Performance Overview: REMEDY.HE

Trailing total returns as of 11/19/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

REMEDY.HE
49.53%
MSCI WORLD
17.45%

1-Year Return

REMEDY.HE
52.52%
MSCI WORLD
24.69%

3-Year Return

REMEDY.HE
67.12%
MSCI WORLD
15.37%

5-Year Return

REMEDY.HE
25.60%
MSCI WORLD
62.84%

Compare To: REMEDY.HE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: REMEDY.HE

View More

Valuation Measures

Annual
As of 11/18/2024
  • Market Cap

    179.18M

  • Enterprise Value

    160.15M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.63

  • Price/Book (mrq)

    2.74

  • Enterprise Value/Revenue

    4.08

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -47.28%

  • Return on Assets (ttm)

    -11.17%

  • Return on Equity (ttm)

    -25.47%

  • Revenue (ttm)

    39.26M

  • Net Income Avi to Common (ttm)

    -18.56M

  • Diluted EPS (ttm)

    -1.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    23.12M

  • Total Debt/Equity (mrq)

    6.27%

  • Levered Free Cash Flow (ttm)

    -588k

Research Analysis: REMEDY.HE

View More

Company Insights: REMEDY.HE

Research Reports: REMEDY.HE

View More

People Also Watch